Alzheimer's disease: Aspects of contemporary pharmacological treatment;Alzheimerova demence: Aspekty současné farmakologické léčby

Ceska a Slovenska Farmacie

Volumn 60, Issue 5, 2011, Pages 219-228

  Drtinová, Lucie ^a   Pohanka, Miroslav ^a  

^a Univerzita Obrany   (Czech Republic)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Donepezil; Galantamine; Memantine; Rivastigmine

Indexed keywords

DONEPEZIL; ETANERCEPT; GALANTAMINE; HUPERZINE A; MEMANTINE; METHYLENE BLUE; RIVASTIGMINE; TAU PROTEIN;

AGNOSIA; ALZHEIMER DISEASE; AMYLOID PLAQUE; APHASIA; APRAXIA; BRAIN ATROPHY; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG MECHANISM; EXCITOTOXICITY; HUMAN; REVIEW;

EID: 81355154857     PISSN: 12107816     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Launer, L. J., Fratiglioni, L., Andersen, K., Breteler, M. M. B., Copeland, R. J. M., Dartiques, J. F., Lobo, A., Martinez-Lage, J., Soininen, H., Hofman, A.: Regional differences in the incidence of dementia in Europe: EURODEM collaborative analyses 1999.
2. Colective authors of alzheimer europe organization: Dementia in Europe Yearbook 2008; 20, (1-178).
3. Weiner, M. W., Aisen, P. S., Clifford, R. J. Jr., Jagust, W. J., Trojanowski, J. Q., Shaw, L., Saykin, A. J., Morris, J. C., Cairns, N., Beckett, L. A., Toga, A., Green, R.,Walter, S., Soares, H., Snyder, P., Siemers, E., Potter, W., Cole, P. E., Schmidt, M., The Alzheimer's disease neuroimaging initiative: The Alzheimer's disease neuroimaging iniviative: Progress report and future plans. Alzheimer's & Dementia 2010; 6, 202-211.
4. Ikejima, C., Yasuno, F., Mizukami, K., Sasaki, M., Tanimukai, S., Asada, T.: Prevalence and cause sof early-onset dementia in japan: A population-based study. American stroke journal 2009; 40, 2704-2714.
5. Zanetti, O., Solerte, S. B., Cantoni, F.: Life expectancy in Alzheimer's diseases (AD). Arch. Gerontol. Geriatr. 2009; 49(Suppl 1), 237-243.
6. Wenk, G. L.: Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 2003; 64(Suppl 9), 7-10. (Pubitemid 37040372)
7. Furukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G., Martin, G. M., Fox, M., Mattson, M. P.: Increased activity - regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a cterminal heparin-binding domain. J. Neurochem. 1996; 67(5), 1882-1896. (Pubitemid 26349661)
8. Shankar, G. M., Li, S., Mehta, T. H., Garcia-Muñoz, A., Shepardson, N. E., Schmidt, J., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., Regan, C. M., Walsh, D. M., Sabatini, B. L., Selkoe, D. J.: Amyloid beta-protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory. Nat. Med. 2008; 14, 837-842.
9. Beeri, M. S., Rapp, M., Silverman, J. M., Schmiedler, J., Grossman, M. T., Fallon, J. T., Purohit, D. P., Perl, D. P., Sidpiqui, A., Lesser, G., Rosendorff, G., Haroutunian, V.: Coronary arthery diseases associated with AD neurology APO E4 carriers. Neurology 2006; 66, 1399-1404. (Pubitemid 43739650)
10. Alzheimer Association Report.: 2010 Alzheimer's disease fact and figures. Alzheimer's & Dementia 2010; 6, 158-194.
11. Jungsu, K., Basak, J. M., Holtzman, D. M.: The role of apolipoproteine in Alzheimer's disease. Neuron 2009;, 63, 287-303.
12. Wei, Y., Qu, M. H., Wang, X. S., Chen, L., Wang, D. L., Liu, Y., Hua, Q., He, R. S.: Binding to the minor groove of the double-stand, tau protein prevents DNA from damage by peroxidation. PLoS One 2008; 3, e2600.
13. Rothman, S. M.: The neurotoxicity of excitatory aminoacids is produced by passive chloride influx. J. Neurosci. 1985; 5, 1483-1489. (Pubitemid 15041463)
14. Liu, D., Pitta, M., Lee, J. H. et al.: The K-ATP channel activator diazoxide ameliorates amyloid-beta and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease. J. Alzheimers Dis. 2010; 22, 443-457.
15. Salter, M. W., Kalia, L. V.: Src kinase: A hub for NMDA receptor regulation. Nature reviews neuroscience 2004; 5, 317-328. (Pubitemid 38478658)
16. Gurland, B. J., Wilder, D. E., Lantigua, R., Stern, Y., Chen, J., Killerffer, E. H. P. et al.: Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry 1999; 14, 481-493. (Pubitemid 29286854)
17. Kim, H., Bang, O. Y., Jung, M. W., Ha, S. D., Hong, H. S., Huh, K., Kim, S. U., Mook-Jung, I.: Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neuroscience Letters 2001; 302, 58-62. (Pubitemid 32244196)
18. Plassman, B. L., Langa, K. M., Fischer, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B. et al.: Prevence of dementia the united states: The aging, demographic and memory study. Neuroepidemiology 2007; 29, 125-132. (Pubitemid 350191430)
19. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E. M.: Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34, 939-944. (Pubitemid 14076461)
20. Guerrero-Berroa, E., Luo, X., Schmiedler, J. et al.: The MMSE orientation for the time domain is a strong predictor of subsequent cognitive decline in the elderly. Int. J. Geriatr. Psychiatry 2009; 24, 1429-1437.
21. Hodkinson, H. M.: Evaluation of a mental test score for assessment of mental impairment in the elderly. Oxford Journal 2010; 1, 233-238.
22. Bullock, R., Bergman, H., Touchon, J., Gambina, G., He, Y., Nagel, J., Lane, R.: Effect of age on respons on rivastigmine or donepezil in patient with Alzheimer's disease. Curr Med Res Opin. 2006; 22, 483-494.
23. Birks, J., Harvey, R. J.: Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst. Rev. 2003; 3, CD001190.
24. Muller, T.: Rivastigmine in the treatment of pacients with Alzheimer's disease. Neuropsychiatr. Dis. Treat. 2007; 3, 211-218. (Pubitemid 46864060)
25. Huang, F., Fu, Y.: A review of clinical pharmacokinetics and pharmacodynamics of galantamine, a reversible acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, in healthy subjects and pacients. Curr Clin Pharmacol. 2010; 5, 115-124.
26. Gomolin, I. H., Smith, C., Jeitner, T. M.: Once-daily memantine: pharmacokinetics and clinical considerations. J. AM Geriatr Soc. 2010; 58, 1812-1813.
27. Drawn form: www.emea.europa.eu/docs/cs-CZ/docu ment-library/EPAR-Product- Information/ human/000463/WC500058763.pdf
28. Goertelmeyer, R., Erbler, H.: Memantin in treatment of milf to moderate dementia syndrome. A double-blind placebo-controlled study. Arzneimittelforschung 1992; 42, 904-913.
29. No Authors Listed. EGb 761: Ginkgo biloba extract, Ginkor. Drug RD 2003; 4(3), 188-193.
30. Loew, D.: Value of Ginkgo biloba in treatment of Alzheimer dementia. Wien Med Wochenschr. 2002; 152, 418-422. (Pubitemid 34984936)
31. Keil, U., Scherping, I., Hauptman, S., Schuessel, K., Eckert, A., Muller, W. E.: Piracetam improves mitochondrial dysfunction following oxidative stress. Br. J. Pharmacol. 2006; 147, 199-208. (Pubitemid 43151568)
32. Martin, K. J., Vyas, S.: Increase in acetylcholine concentrations in the brain of "old" rats following treatment with pyritinol (Encephabol). Br. J. Pharmacol. 1987; 90, 561-565. (Pubitemid 17022603)
33. Mazzon, E., Esposito, E., Di Paola, R., Muia, C., Crisafulli, C., Genovese, T., Caminiti, R., Měli, R., Bramanti, P., Cozzocrea, S.: Effect of tumorous necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute imflammation: A comparison with etanercept. Clin. Exp. Immunol. 2008; 153, 136-149. (Pubitemid 351809337)
34. Combe, B.: Update on the use of etanercept across a spectrum of rheumatoid disorders. Biologics 2008; 2, 165-173.
35. Wischik, C., Staff, R.: Challenges in the conduct of disease - modyfying trials in AD: Practical experience from phase 2 trial of Tau-aggregation inhibition therapy. Journal of Nutrition Health & Aging 2009; 13, 367-369.
36. Wischik, C., Edwards, P. C., Lai, R. Y., Roth, M., Harrington, C. R.: Selective inhibition of alzheimer's disease - like tau aggregation by phenothiazines. Proc. Natl. Acad. Sci. USA 1996; 93, 11213-11218. (Pubitemid 26333144)
37. Ho, Y., So, K., Chuen-Chung Chang, R.: Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia. Chin. Med. 2011; 6, 15.